Managing diabetes with nanomedicine: challenges and opportunities
Nanotechnology-based approaches hold substantial potential for improving the care of patients with diabetes. Nanoparticles are being developed as imaging contrast agents to assist in the early diagnosis of type 1 diabetes. Glucose nanosensors are being incorporated in implantable devices that enable...
Main Authors: | Langer, Robert S, Anderson, Daniel Griffith, Veiseh, Omid, Tang, Benjamin C., Whitehead, Kathryn Ann |
---|---|
Other Authors: | Massachusetts Institute of Technology. Institute for Medical Engineering & Science |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2017
|
Online Access: | http://hdl.handle.net/1721.1/109215 https://orcid.org/0000-0003-4255-0492 https://orcid.org/0000-0001-5629-4798 https://orcid.org/0000-0002-0100-7824 |
Similar Items
-
Nanomedicines for endothelial disorders
by: Toth, Michael J., et al.
Published: (2018) -
Nanomedicine in the management of microbial infection – Overview and perspectives
by: Zhu, Xi, et al.
Published: (2021) -
Nanomedicine in the management of microbial infection – Overview and perspectives
by: Zhu, Xi, et al.
Published: (2022) -
Chiral Supraparticles for Controllable Nanomedicine
by: Yeom, Jihyeon, et al.
Published: (2021) -
Engineering synthetically modified insulin for glucose-responsive diabetes therapy
by: Webber, Matthew, et al.
Published: (2019)